These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37030500)
21. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach. Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368 [TBL] [Abstract][Full Text] [Related]
22. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome. Canet-Hermida J; Marín F; Dorca E; Dueñas N; Costas L; Salinas M; Velasco À; Peremiquel-Trillas P; Paytubi S; Ponce J; Fernández S; Martínez JM; Cárdenas L; Taltavull A; Alemany L; Meléndez C; Oliveras G; Vidal A; Capellá G; López-Bonet E; Brunet J; Matias-Guiu X; Pineda M Mod Pathol; 2023 Jul; 36(7):100158. PubMed ID: 36918055 [TBL] [Abstract][Full Text] [Related]
23. Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters. Staffa L; Echterdiek F; Nelius N; Benner A; Werft W; Lahrmann B; Grabe N; Schneider M; Tariverdian M; von Knebel Doeberitz M; Bläker H; Kloor M PLoS One; 2015; 10(3):e0121980. PubMed ID: 25816162 [TBL] [Abstract][Full Text] [Related]
24. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands. Walker R; Mahmood K; Como J; Clendenning M; Joo JE; Georgeson P; Joseland S; Preston SG; Pope BJ; Chan JM; Austin R; Bojadzieva J; Campbell A; Edwards E; Gleeson M; Goodwin A; Harris MT; Ip E; Kirk J; Mansour J; Mar Fan H; Nichols C; Pachter N; Ragunathan A; Spigelman A; Susman R; Christie M; Jenkins MA; Pai RK; Rosty C; Macrae FA; Winship IM; Buchanan DD; Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894291 [TBL] [Abstract][Full Text] [Related]
25. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors. Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238 [TBL] [Abstract][Full Text] [Related]
26. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency. Clay MR; Allison KH; Folkins AK; Longacre TA Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635 [TBL] [Abstract][Full Text] [Related]
27. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis. Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091 [TBL] [Abstract][Full Text] [Related]
28. The Relationship Between DNA Mismatch Repair Status and Clinicopathologic Characteristics in Colon Cancer. Doğan M; Kılıç M; Tatlı Doğan H Turk J Gastroenterol; 2024 Aug; 35(9):718-725. PubMed ID: 39344689 [TBL] [Abstract][Full Text] [Related]
29. Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice. Leicher LW; Lammertink MHA; Offerman SR; Morreau H; de Jong MM; de Groot JWB; van Westreenen HL; Vasen HFA; de Vos Tot Nederveen Cappel WH Scand J Gastroenterol; 2018 May; 53(5):632-636. PubMed ID: 29161904 [TBL] [Abstract][Full Text] [Related]
30. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions? Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610 [TBL] [Abstract][Full Text] [Related]
31. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation. Kaya M; Post CCB; Tops CM; Nielsen M; Crosbie EJ; Leary A; Mileshkin LR; Han K; Bessette P; de Boer SM; Jürgenliemk-Schulz IM; Lutgens L; Jobsen JJ; Haverkort MAD; Nout RA; Kroep J; Creutzberg CL; Smit VTHBM; Horeweg N; van Wezel T; Bosse T Mod Pathol; 2024 Mar; 37(3):100423. PubMed ID: 38191122 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India. Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011 [TBL] [Abstract][Full Text] [Related]
35. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas. Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743 [TBL] [Abstract][Full Text] [Related]
37. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
38. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer. Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ Front Immunol; 2019; 10():3023. PubMed ID: 31998307 [TBL] [Abstract][Full Text] [Related]
39. Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China. Zhao G; Xiang G; Hu X; Qiao Y; Ma S; Tian Y; Gao X; Liu F; Li X; Shi G Eur J Cancer Prev; 2023 Jul; 32(4):337-347. PubMed ID: 36942852 [TBL] [Abstract][Full Text] [Related]
40. Somatic Sequencing and Microsatellite Instability Results From Mismatch Repair-deficient Endometrial Carcinoma Patients Without Lynch Syndrome ("Lynch-like" tumors): Implications for Heritable Cancer Screening, Molecular Prognostication, and Immunotherapeutic Vulnerability. Makia NL; Thomas M; Ring KL; Moskaluk CA; Mills AM Am J Surg Pathol; 2023 Aug; 47(8):878-888. PubMed ID: 37248962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]